Total Non-Current Liabilities

$16.45B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$16.45Bperiod endingJun 30, 2026

TEVA Quarterly Total Non-Current Liabilities ($45.60M → $16.45B)

Quarterly total non-current liabilities

High-resolution chart · PNG

TEVA total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2001	889,409,000
Mar 31, 2001	913,684,000
Dec 31, 2000	918,880,000
Sep 30, 2000	522,002,000
Jun 30, 2000	408,404,000
Mar 31, 2000	428,680,000
Dec 31, 1999	434,147,000
Sep 30, 1999	349,900,000
Jun 30, 1999	247,700,000
Mar 31, 1999	236,400,000
Dec 31, 1998	238,800,000
Sep 30, 1998	218,000,000
Jun 30, 1998	215,700,000
Mar 31, 1998	130,100,000
Dec 31, 1997	148,000,000
Dec 31, 1996	184,500,000
Dec 31, 1995	62,000,000
Dec 31, 1994	93,800,000
Dec 31, 1993	84,300,000
Dec 31, 1992	52,100,000
Dec 31, 1991	70,700,000
Dec 31, 1990	91,600,000
Dec 31, 1989	86,100,000
Dec 31, 1988	58,400,000
Mar 31, 1987	38,900,000
Mar 31, 1986	45,600,000